- Home
- SWIN vs DYAI Comparison
SWIN vs DYAI Comparison
Compare SWIN & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- DYAI
- Stock Information
- Founded
- SWIN 2017
- DYAI 1979
- Country
- SWIN Hong Kong
- DYAI United States
- Employees
- SWIN N/A
- DYAI N/A
- Industry
- SWIN
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SWIN
- DYAI Health Care
- Exchange
- SWIN Nasdaq
- DYAI Nasdaq
- Market Cap
- SWIN 214.1M
- DYAI 28.3M
- IPO Year
- SWIN 2023
- DYAI 2004
- Fundamental
- Price
- SWIN $3.94
- DYAI $1.13
- Analyst Decision
- SWIN
- DYAI Strong Buy
- Analyst Count
- SWIN 0
- DYAI 1
- Target Price
- SWIN N/A
- DYAI $6.00
- AVG Volume (30 Days)
- SWIN 216.6K
- DYAI 199.4K
- Earning Date
- SWIN 08-21-2025
- DYAI 08-12-2025
- Dividend Yield
- SWIN N/A
- DYAI N/A
- EPS Growth
- SWIN N/A
- DYAI N/A
- EPS
- SWIN N/A
- DYAI N/A
- Revenue
- SWIN $3,316,000.00
- DYAI $3,554,344.00
- Revenue This Year
- SWIN $29.79
- DYAI $22.56
- Revenue Next Year
- SWIN $54.60
- DYAI $30.95
- P/E Ratio
- SWIN N/A
- DYAI N/A
- Revenue Growth
- SWIN N/A
- DYAI 57.59
- 52 Week Low
- SWIN $1.16
- DYAI $0.91
- 52 Week High
- SWIN $4.40
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- SWIN 59.60
- DYAI 71.14
- Support Level
- SWIN $3.29
- DYAI $0.98
- Resistance Level
- SWIN $3.99
- DYAI $1.20
- Average True Range (ATR)
- SWIN 0.39
- DYAI 0.09
- MACD
- SWIN -0.04
- DYAI 0.02
- Stochastic Oscillator
- SWIN 80.93
- DYAI 65.28
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.